105 related articles for article (PubMed ID: 303542)
1. Effect of sequence of administration of methotrexate, leucovorin, and 5-fluorouracil on mammary tumor growth and survival in syngeneic C3H mice.
Heppner GH; Calabresi P
Cancer Res; 1977 Dec; 37(12):4580-3. PubMed ID: 303542
[TBL] [Abstract][Full Text] [Related]
2. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
3. The effect of Corynebacterium parvum in combination with 5-fluorouracil, L-phenylalanine mustard, or methotrexate on the inhibition of tumor growth.
Fisher B; Rubin H; Saffer E; Wolmark N
Cancer Res; 1976 Aug; 36(8):2714-9. PubMed ID: 1277181
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
Heppner GH; Dexter DL; DeNucci T; Miller FR; Calabresi P
Cancer Res; 1978 Nov; 38(11 Pt 1):3758-63. PubMed ID: 698935
[TBL] [Abstract][Full Text] [Related]
5. Selective expansion of 5,10-methylenetetrahydrofolate pools and modulation of 5-fluorouracil antitumor activity by leucovorin in vivo.
Wright JE; Dreyfuss A; el-Magharbel I; Trites D; Jones SM; Holden SA; Rosowsky A; Frei E
Cancer Res; 1989 May; 49(10):2592-6. PubMed ID: 2785434
[TBL] [Abstract][Full Text] [Related]
6. Effects of combination drug therapy on the subcutaneous and pulmonary growth of a slow and a fast-growing C3H/He mammary carcinoma.
Vaage J; Costanza ME
Cancer Res; 1979 Nov; 39(11):4466-71. PubMed ID: 498077
[TBL] [Abstract][Full Text] [Related]
7. Localized chemotherapy of Gardner's lymphosarcoma of C3H mice using combinations of carrier-sorbed antifolics and detoxicating tetrahydrofolates.
Motycka K; Slavík K; Balcarová A; Spacek P; Kubín M
Czech Med; 1981; 4(1-2):14-24. PubMed ID: 6973453
[TBL] [Abstract][Full Text] [Related]
8. Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.
Sirotnak FM; Moccio DM; Dorick DM
Cancer Res; 1978 Feb; 38(2):345-53. PubMed ID: 304375
[TBL] [Abstract][Full Text] [Related]
9. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
[TBL] [Abstract][Full Text] [Related]
10. Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer.
Benz C; Tillis T; Tattelman E; Cadman E
Cancer Res; 1982 May; 42(5):2081-6. PubMed ID: 6175406
[TBL] [Abstract][Full Text] [Related]
11. Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.
Machiavelli M; Leone BA; Romero A; Rabinovich MG; Vallejo CT; Bianco A; Pérez JE; Rodríguez R; Cuevas MA; Alvarez LA
Am J Clin Oncol; 1991 Jun; 14(3):211-7. PubMed ID: 2031508
[TBL] [Abstract][Full Text] [Related]
12. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
Nitta K; Tanaka T; Takeuchi M
Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
[TBL] [Abstract][Full Text] [Related]
13. Treatment of solid Gardner lymphosarcoma with methotrexate sorbed on 2-hydroxyethylmethacrylate polymer in combination with leukovorin.
Motycka K; Slavík K; Balcarbová A; Cihar R; Spacek P; Kubín M
Neoplasma; 1978; 25(2):217-25. PubMed ID: 306074
[TBL] [Abstract][Full Text] [Related]
14. Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil.
Bertino JR; Sawicki WL; Lindquist CA; Gupta VS
Cancer Res; 1977 Jan; 37(1):327-8. PubMed ID: 830420
[TBL] [Abstract][Full Text] [Related]
15. Biochemical modulation of combined radiation and 5-fluorouracil treatment of murine tumors by d,l-leucovorin.
Kovacs CJ; Dainer PM; Evans MJ; Nyce J
Anticancer Res; 1991; 11(2):905-9. PubMed ID: 2064349
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
[TBL] [Abstract][Full Text] [Related]
17. Selective immunosuppression by drugs in balanced immune responses.
Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
[No Abstract] [Full Text] [Related]
18. Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors.
Braunschweiger PG; Stragand JJ; Schiffer LM
Cancer Res; 1978 Dec; 38(12):4510-4. PubMed ID: 719635
[No Abstract] [Full Text] [Related]
19. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of antitumor immunity in tumor-bearing mice by a degraded D-manno-D-glucan (DMG), a new antitumor polysaccharide.
Nakajima H; Kita Y; Hashimoto S; Tsukada W; Abe S; Mizuno D
Jpn J Exp Med; 1983 Dec; 53(6):281-8. PubMed ID: 6680757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
